APO-HYDROMORPHONE
APOTEX INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-HYDROMORPHONE in Canada?
Yes. APO-HYDROMORPHONE 8MG has an active shortage reported to Health Canada (last updated September 25, 2026).
Why is APO-HYDROMORPHONE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-HYDROMORPHONE be available again?
The manufacturer's estimated resolution date is October 2, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
DILAUDID
PURDUE PHARMA
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG
PURDUE PHARMA
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG
PURDUE PHARMA
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG
PURDUE PHARMA
PMS-HYDROMORPHONE TAB 4MG
PHARMASCIENCE INC
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG
PURDUE PHARMA
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02364158
Strength
8MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178